Back to UBS Group AG UBS Group AG

AXSMAXSM
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in AXSOME THERAPEUTICS INC

UBS Group AG holds 151,903 shares of AXSM (AXSOME THERAPEUTICS INC), worth $37.2M as of 2026-Q2. The position was decreased (-72.2% shares). AXSM represents 0.0% of UBS Group AG's portfolio.

Current Value

$37.2M

Current Shares

151,903

Total Value Change

+$32.9M

Total Shares Change

+104,141

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
151,903
-72.2%
$37.2M0.0%$244.77
0
2026-Q1
Increased
547,195
+54.0%
$92.5M0.0%$164.05
42
2025-Q4
Increased
355,318
+67.3%
$64.9M0.0%$148.79
44
2025-Q3
Decreased
212,451
-64.3%
$25.8M0.0%$117.62
0
2025-Q2
Increased
595,455
+106.3%
$62.2M0.0%$103.36
48
2025-Q1
Increased
288,647
+95.9%
$33.7M0.0%$118.53
46
2024-Q4
Increased
147,347
+208.5%
$12.5M0.0%$84.78
45
2024-Q3
Increased
47,762
+20.3%
$4.3M0.0%$89.64
32

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used